We are writing as leaders of research centers at University of Washington Medicine focused on combating the effects of age and Alzheimer’s disease on quality of life. While the National Institutes of ...

UW has begun treating patients with donanemab, a new Alzheimer’s medication that may slow cognitive decline in people with ...

SEATTLE — There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears ...

Dozens of high school students from Spokane County explored medical careers through hands-on experience at the University of Washington School of Medicine.